港股创新药ETF（159567）成立于2024年1月3日，基金全称为银华国证港股通创新药交易型开放式指数 证券投资基金，基金简称为港股创新药ETF。该基金管理费率每年0.50%，托管费率每年0.10%。港股创 新药ETF（159567）业绩比较基准为国证港股通创新药指数收益率(经估值汇率调整)。 规模方面，截止11月13日，港股创新药ETF（159567）最新份额为96.65亿份，最新规模为85.79亿元。 回顾2024年12月31日，港股创新药ETF（159567）份额为3.95亿份，规模为3.78亿元。即该基金今年以 来份额增加2344.51%，规模增加2170.81%。 来源：新浪基金∞工作室 11月14日，港股创新药ETF（159567）收盘跌1.12%，成交额22.14亿元。 流动性方面，截止11月14日，港股创新药ETF（159567）近20个交易日累计成交金额280.57亿元，日均 成交金额14.03亿元；今年以来，210个交易日，累计成交金额2512.14亿元，日均成交金额11.96亿元。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评 ...

初冬暖阳洒落黄浦江畔，11月12日至13日，2025年上海证券交易所国际投资者大会召开。全球百余 家知名投资机构、近400名代表共赴"上海之约"，透过中国资产，瞭望世界经济。 正如中国证监会副主席李明在大会致辞中所言，在"十四五"即将顺利收官、"十五五"整装待发的重 要历史时刻，本次大会以"价值引领开放赋能"为主题，聚焦中国资本市场的长期投资价值与高水平对外 开放，可谓正当其时，具有重要意义。 "我们将全力为境内外金融机构、金融企业、金融人才创造更多市场机遇、发展机遇，诚挚欢迎大 家来沪展业、兴业，为上海国际金融中心建设作出贡献。"上海市常务副市长吴伟在大会上表示。 在全球经济充满不确定性的当下，上海如何更好地发挥金融"压舱石"作用，把中国的"新质生产 力"与全球创新链深度融合？以此为原点，上海国际金融中心建设的"十五五"新征程脉络已然清晰。这 座城市正持续创造机遇，向全球金融机构与人才发出合作共赢的时代邀约。 全球引力场 当今世界，百年变局加速演进，全球经济金融形势更趋复杂严峻，不确定性上升。风高浪急之 下，"压舱石"的价值愈发凸显。作为上交所面向全球投资界的重要年度会议，本届大会共吸引来自欧 美、亚太及中 ...

华福证券指出，医药生物行业近期呈现结构性机会。内镜板块迎来新品集中上市，2025年奥林巴斯X1 国产镜体、开立医疗HD-650及澳华内镜AQ-400等高端产品获批，有望驱动新一轮设备更新需求，国产 厂商招投标金额同比高增且市占率加速提升。医疗设备板块维持高景气，24M12-25M9超声、CT等子类 招投标平均增速超30%，预计2026年行业库存回归常规水平后将迎来业绩拐点。创新药领域，2025年国 家医保谈判新增127个目录外药品，叠加商保创新药目录扩容，支付端持续改善；全球减肥药市场动态 活跃，辉瑞收购Metsera，诺和诺德与礼来宣布2026年起降价以提升可及性。当前医药板块调整超2个 月，估值溢价率处于历史低位，创新药、CXO及医疗设备等主线产业趋势明确，性价比凸显。 疫苗ETF（159643）跟踪的是疫苗生科指数（980015），该指数从市场中选取涉及生物制品、生命科学 工具和服务等领域的上市公司证券作为指数样本，重点关注疫苗研发、生产及相关服务的企业。成分股 具有显著的创新性和成长性特征，能够综合反映疫苗与生物科技行业的整体表现及技术发展动态。 注：如提及个股仅供参考，不代表投资建议。指数/基金短期 ...

Group 1 - The A-share market showed weakness today, influenced by a drop of over 2% in the Nasdaq, with the Shanghai Composite Index closing at 3990.49 points, down 0.97% [1] - The market experienced a mixed performance this week, with multiple attempts to break the 4000-point mark, reflecting underlying participant divergence despite initial optimism [1] - The trading volume in both Shanghai and Shenzhen markets was below 2 trillion, indicating a lack of active trading [1] Group 2 - The market has been searching for new leading narratives since the CPO sector, with sectors like new energy and battery showing temporary strength but lacking sustainability [2] - Economic indicators such as social financing are showing mediocre performance, indicating a lag in the recovery of confidence in the real economy [2] - The pressure from profit-taking in certain sectors, where some stocks have seen gains exceeding 50%, poses a risk to the continuation of the current market trend [2] Group 3 - Investors are advised to avoid unilateral bets and consider a strategy of high selling and low buying, focusing on a "core position + satellite rotation" approach [3] - Recommended core ETFs include the CSI A500 ETF and the CSI 300 Enhanced ETF, while satellite opportunities may arise in sectors that have underperformed during the recent adjustments [3] - The Hong Kong and US markets showed weaker performance compared to A-shares, with the Hang Seng and Hang Seng Tech indices closing below water, reflecting higher sensitivity to US dollar liquidity [3]

盘面上，科网股普跌，百度集团-SW（09888.HK）跌超7%；京东集团-SW（09618.HK）跌超6%；阿里 巴巴-W（09988.HK）跌超4%；小米、联想跌超3%；快手跌超2%；美团、哔哩哔哩跌超1%。 今日（11月14日），港股市场全天走弱。 截至收盘，恒指报收于26572.46点，下跌500.57点，跌幅1.85%。 | 分时 2日 = 5分 15分 30分 60分 日照 周K 月K 第K = | | HMR+ MB = M / : 恒生指数 (HSU) | | | | | | --- | --- | --- | --- | --- | --- | --- | | 餐生種數 共性 .. | | | | | 1 200 27 | | | | -27381.84 | 0000 | | 26572.46 | | + | | | | | 行情报价 | | | | | | | 27000 0 | 成交量 | 148亿 最高 | -26481.88 今月 | 20460.31 | | | | | 成立程 | 2328亿 最低 | 26535.42 图像 | 27073.03 | | | | 26500.0 | ...

Market Performance - The Shanghai Composite Index fell by 0.97%, closing below 4000 points, while the ChiNext Index dropped by 2.82% [1] - The Hang Seng Index and the Hang Seng Tech Index experienced significant declines, with the latter falling by 2.83% and reaching a low of 3.1% during trading [1] - For the week, the Hang Seng China Enterprises Index and the Hang Seng Index rose by 1.4% and 1.26%, respectively, while the Shanghai Composite Index saw a slight decline of 0.18% [1][2] ETF Performance - The "Global Vision, Betting on China" top ten core ETFs saw a minor pullback of 0.325% this week but recorded a year-to-date increase of 32.62%, outperforming the CSI 300 Index by 15 percentage points [3] - The Hong Kong Innovative Drug ETF was the best performer this week, rising by 5.9% and achieving a year-to-date increase of 93% [7] - The A500 ETF (512050) experienced a slight decline of 1.02% this week but had a net inflow of 2.36 billion yuan over the first four days of the week, totaling 27.07 billion yuan over the past 20 days [3][6] Innovative Drug Sector - The innovative drug sector is showing strong fundamentals, with companies like BeiGene reporting a 41.1% year-on-year revenue increase in Q3, reaching 10.077 billion yuan [9] - The sector is benefiting from a surge in overseas licensing deals, with total transaction amounts exceeding 100 billion USD by October 2025, indicating a significant revaluation of domestic innovative drugs [9] - Policy support, performance realization, and accelerated internationalization are driving improvements in the innovative drug sector's fundamentals, enhancing its medium to long-term investment value [9] U.S. Market Dynamics - The U.S. stock market is facing liquidity challenges due to a prolonged government shutdown and increased debt issuance, which has led to a significant cash drain from the market [12][13] - Hedge funds and institutions have been net sellers of U.S. stocks and ETFs, with over 67 billion USD sold this year, exacerbating liquidity pressures [13] - The Federal Reserve's mixed signals on interest rates have created volatility, particularly affecting technology stocks, as the market adjusts to changing rate expectations [12][14]

最近的市场依旧很是复杂，大盘继续创下新高。热点上一天科技、一天红利轮动。科技属性的创新药、新能源走势强劲。市场不像之前有明确的主线，各 个小热点纷至沓来。 最近，"老登股""小登股"讨论火热，前者就是传统的行业，后者是科技成长企业。从这个思路出发，以年龄为区分，找了一些"小登基金经理"和"老登基 金经理"。 首先明确一下，从主动权益基金里筛选，限定在主动权益基金：普通股票、偏股混合、灵活配置，且股票仓位>50%。多位基金经理，以第一位数据计 算。 那么下面筛选"小登基金经理"： 管理基金年限1～3年 基金成立时间>1年、基金规模>1亿 今涨幅>50%，最大回撤20%以内 剔除C类 共计筛选出26个，如下： | | | | 26位"小登"基金经理 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2017 基金名称 | 成立年限 | 基金经理 | 基金规模 | 基金经理 | 今年 | 近3年 | 最大回撤% | 股票 | 机构 | | | | | 112 | 年限 | 回报% | 回报% | (今年以来) ...

今日早盘，A股三大指数震荡调整，板块题材上，海南自贸区、医药、油气、银行等板块涨幅居前，锂业、存储、CPO等板块调整；港股整体调 整，创新药板块领涨，昨日尾盘拉升的科技股集体回调。截至午间收盘，中证A500指数、沪深300指数均下跌0.8%，创业板指数下跌1.7%，上证 科创板50成分指数下跌1.5%，恒生中国企业指数下跌1.4%。 该指数 滚动市盈率 该指数自2002年 以来估值分位 67. 6% 注1: "该捐款" 作者上述基金产品具体调節的捐款。敷配未自Urd，排数流发幅截逐2025年11月14日午间收盘、湖动市温馨。估值分位数至2025年11月13日，深动市查罩半总市值 / 近四个季度日期母 公司股东的净利润、该估值影标和企业登利紧密相关，适用于盈利相对稳定且受周期影响较小的行业。估值分位指该摘像历史上球动市盈率低于当前滚动市盈率的时间占比，估值分位优表示相对便宜。 估值分位区间为捐赠发布日起至2025年11月13日。沪深300捐数2026年4月8日发布，中证A500指数2024年9月23日发布，可查询估值记录员为2004年12月31日起，估值分位区间为2004年12月31日至2025年 11月13日 ...

Market Overview - The recent market structure opportunities are primarily concentrated in the new energy and AI sectors, with some trending concepts like "milk skin candy hawthorn" and "survival in the wild" gaining attention [3] - The banking sector showed strength, with all major banks' stocks rising, and Agricultural Bank and Industrial and Commercial Bank reaching historical highs during intraday trading [3] Stock Performance - As of the morning close, the Shanghai Composite Index fell by 0.16%, the Shenzhen Component Index decreased by 1.1%, and the ChiNext Index dropped by 1.74% [4] Trending Concepts - The "survival in the wild" challenge in Zhangjiajie has gained popularity, leading to active performance in related stocks like Sanfu Outdoor, which rose over 6% and hit the daily limit [6] - Joyoung Co., Ltd. saw its stock hit the daily limit as it launched a new product, "Haki Mi North and South Green Bean Milk," which became popular on e-commerce platforms due to its association with internet memes [6][7] Pharmaceutical Sector - The pharmaceutical sector showed strength, with significant gains in pharmaceutical commerce, flu-related stocks, and innovative drugs [9] - The overall flu activity in China is currently at a rising stage, with the H3N2 subtype dominating, and 23 provinces experiencing moderate flu levels [12] - Innovative drug leader BeiGene reported a revenue of 27.595 billion yuan for the first three quarters of 2023, a 44.2% year-on-year increase, with a net profit of 1.139 billion yuan [12]

Group 1: Market Trends - Recent market structural opportunities are primarily focused on the new energy and AI sectors, with attention also on trending concepts like "milk skin candy hawthorn" and "survival in the wild" [1] - The banking sector showed strength, with all major banks' stocks rising, and Agricultural Bank and Industrial and Commercial Bank reaching historical highs during intraday trading [1] Group 2: Trending Concepts - The "survival in the wild" challenge in Zhangjiajie has gained significant popularity, leading to active performance in related stocks such as Sanfu Outdoor, which saw a rise of over 6% and briefly hit the daily limit [2] - Juyuan Co. (Jiuyang) experienced a "limit up" on the stock market due to the viral success of its new product "Haki Mi North-South Mung Bean Milk," which became popular through social media trends [3] Group 3: Pharmaceutical Sector - The pharmaceutical sector showed strong performance, particularly in areas like pharmaceutical commerce, flu treatments, and innovative drugs [4] - The overall flu activity in China is currently at a rising stage, with the H3N2 subtype dominating, and 23 provinces experiencing medium levels of flu activity [7] - Innovative drug leader BeiGene reported third-quarter earnings that exceeded market expectations, with a revenue of 27.595 billion yuan, reflecting a year-on-year growth of 44.2% [7]